TRIPALMITIN is a lipid of Glycerolipids (GL) class. Tripalmitin is associated with abnormalities such as Atherosclerosis, Hypoalphalipoproteinemias, Cystic Fibrosis, PARKINSON DISEASE, LATE-ONSET and Obesity. The involved functions are known as 5-(carboxyamino)imidazole ribonucleotide mutase activity, Certification, phosphatidylcholine-sterol O-acyltransferase activity, Regulation and Uptake. Tripalmitin often locates in Blood, Hepatic, Body tissue, Gastric mucosa and Biopsy sample. The associated genes with TRIPALMITIN are PON1 gene, very high density lipoproteins, THEMIS gene, HEPATIC PROTEIN and chylomicron remnant. The related lipids are Fatty Acids, Total cholesterol, Nonesterified Fatty Acids, Palmitates and tristearin.
To understand associated biological information of TRIPALMITIN, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
TRIPALMITIN is suspected in Atherosclerosis, Fatty Liver, Cystic Fibrosis, Hypoalphalipoproteinemias, PARKINSON DISEASE, LATE-ONSET, Obesity and other diseases in descending order of the highest number of associated sentences.
| Disease | Cross reference | Weighted score | Related literature |
|---|
We collected disease MeSH terms mapped to the references associated with TRIPALMITIN
| MeSH term | MeSH ID | Detail |
|---|---|---|
| Cystic Fibrosis | D003550 | 65 associated lipids |
| Leishmaniasis, Visceral | D007898 | 13 associated lipids |
| Malabsorption Syndromes | D008286 | 16 associated lipids |
| Respiratory Distress Syndrome, Newborn | D012127 | 5 associated lipids |
| HIV-Associated Lipodystrophy Syndrome | D039682 | 3 associated lipids |
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
| Location | Cross reference | Weighted score | Related literatures |
|---|
| Function | Cross reference | Weighted score | Related literatures |
|---|
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
| Gene | Cross reference | Weighted score | Related literatures |
|---|
There are no associated biomedical information in the current reference collection.
| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Chen C et al. | Orally delivered salmon calcitonin-loaded solid lipid nanoparticles prepared by micelle-double emulsion method via the combined use of different solid lipids. | 2013 | Nanomedicine (Lond) | pmid:23075315 |
| Delaney WE et al. | Fatty acid breath test values in the malabsorption range in cancer patients. | 1982 | Nutr Cancer | pmid:7134008 |
| Sargsyan E et al. | UPR in palmitate-treated pancreatic beta-cells is not affected by altering oxidation of the fatty acid. | 2011 | Nutr Metab (Lond) | pmid:21978671 |
| Karupaiah T and Sundram K | Effects of stereospecific positioning of fatty acids in triacylglycerol structures in native and randomized fats: a review of their nutritional implications. | 2007 | Nutr Metab (Lond) | pmid:17625019 |
| Soll RF et al. | Multicenter trial of single-dose modified bovine surfactant extract (Survanta) for prevention of respiratory distress syndrome. Ross Collaborative Surfactant Prevention Study Group. | 1990 | Pediatrics | pmid:2187176 |
| Shamma RN et al. | Development of novel sustained release matrix pellets of betahistine dihydrochloride: effect of lipophilic surfactants and co-surfactants. | 2012 Sep-Oct | Pharm Dev Technol | pmid:21770719 |
| Reddy LH et al. | Tamoxifen citrate loaded solid lipid nanoparticles (SLN): preparation, characterization, in vitro drug release, and pharmacokinetic evaluation. | 2006 | Pharm Dev Technol | pmid:16749527 |
| Illing A et al. | Investigation on particle self-assembly in solid lipid-based colloidal drug carrier systems. | 2004 | Pharm. Res. | pmid:15139515 |
| Christophersen PC et al. | Solid lipid particles for oral delivery of peptide and protein drugs II--the digestion of trilaurin protects desmopressin from proteolytic degradation. | 2014 | Pharm. Res. | pmid:24623481 |
| Manjunath K et al. | Preparation and characterization of nitrendipine solid lipid nanoparticles. | 2011 | Pharmazie | pmid:21553647 |
| Ma G and Allen HC | New insights into lung surfactant monolayers using vibrational sum frequency generation spectroscopy. | Photochem. Photobiol. | pmid:16930094 | |
| Widiez T et al. | Functional characterization of two new members of the caffeoyl CoA O-methyltransferase-like gene family from Vanilla planifolia reveals a new class of plastid-localized O-methyltransferases. | 2011 | Plant Mol. Biol. | pmid:21629984 |
| Zhou JM et al. | Biochemical characterization of a putative wheat caffeic acid O-methyltransferase. | 2009 | Plant Physiol. Biochem. | pmid:19211254 |
| Villa CE et al. | Accumulative difference image protocol for particle tracking in fluorescence microscopy tested in mouse lymphonodes. | 2010 | PLoS ONE | pmid:20808918 |
| Carilli J et al. | Historical temperature variability affects coral response to heat stress. | 2012 | PLoS ONE | pmid:22479626 |
| Hellemans KH et al. | Susceptibility of pancreatic beta cells to fatty acids is regulated by LXR/PPARalpha-dependent stearoyl-coenzyme A desaturase. | 2009 | PLoS ONE | pmid:19787047 |
| Vallim T and Salter AM | Regulation of hepatic gene expression by saturated fatty acids. | 2010 Apr-Jun | Prostaglandins Leukot. Essent. Fatty Acids | pmid:20227267 |
| Sol ER et al. | Proteins altered by elevated levels of palmitate or glucose implicated in impaired glucose-stimulated insulin secretion. | 2009 | Proteome Sci | pmid:19607692 |
| DAY AJ | A comparison of the oxidation of cholesterol-26-14C, palmitate-1-14C and tripalmitin-1-14C by macrophages in vitro. | 1961 | Q J Exp Physiol Cogn Med Sci | pmid:13884054 |
| Park KH and Kim HJ | Analysis of fatty acids by graphite plate laser desorption/ionization time-of-flight mass spectrometry. | 2001 | Rapid Commun. Mass Spectrom. | pmid:11507764 |